Identification of Laboratory Biomarkers for Early Detection and Clinical Management of Post-Acute Syndrome Among Survivors of the 2013-2016 West Africa Ebola Outbreak in Sierra Leone.

Raoul Emeric Guetiya WadoumStephen SevalieMaurice Baimba KargboAndrew ClarkeSherry BanguraMariatu KargboHawa Mariama SesayAbdul H KamaraJamil BanguraAlie F KamaraSophie AllieuHassan RogersMaurizio MatteiVittorio ColizziCarla MontesanoEdwin J J Momoh

Published in: Journal of blood medicine (2023)

We recommend clinicians closely monitor Hb, PCV, MCV, MCH, ALT, CREA, C-kinase, T-cholesterol, triglycerides and lymphocytes as clinically relevant laboratory biomarkers to identify survivors at higher risk of developing severe post-acute syndrome upon discharge from Ebola treatment unit including headache, abdominal pain, chest pain, ocular complication, arthralgia, hearing difficulty and erectile dysfunction which can impact health-related quality of life among Ebola survivors.

Keyphrases

liver failure
abdominal pain
young adults
respiratory failure
drug induced
aortic dissection
case report
palliative care
early onset
peripheral blood
intensive care unit
tyrosine kinase
protein kinase
combination therapy
hearing loss
low density lipoprotein